Viewing Study NCT05529069


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-01-03 @ 8:38 PM
Study NCT ID: NCT05529069
Status: RECRUITING
Last Update Posted: 2025-10-24
First Post: 2022-09-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module